Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Innate Pharma Announces the Progression of the Clinical Trial Evaluating NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi to Phase 2 in Various Blood Cancers
Tuesday, April 16, 2024Innate Pharma SA today announces that the first patient has been treated in the Phase dose expansion study led by Sanofi evaluating SARIPH as a monotherapy
Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® (fosdenopterin) for Treatment of MoCD Type A in Great Britain
Tuesday, April 16, 2024Sentynl Therapeutics Inc a USbased biopharmaceutical company whollyowned by Zydus Lifesciences Ltd today announced The Medicines and Healthcare products
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
Monday, April 15, 2024NRx Pharmaceuticals Inc a clinicalstage biopharmaceutical company today announced that the Company has developed a novel proprietary formulation
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
Friday, April 12, 2024Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences Inc a biotechnology company focused on discovering and developing innovative proteinbased immunotherapies today announced that the companies
Nuvation Bio Completes Acquisition of AnHeart Therapeutics
Thursday, April 11, 2024Nuvation Bio Inc a latestage global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates today announced the completion of the acquisition of AnHeart Therapeutic...
Nanoform and Plusvitech Partner to Repurpose Aprepitant as a Treatment for Lung Cancer
Wednesday, April 10, 2024Nanoform Finland Plc the medicine performanceenhancing company today announced a collaboration with PlusVitech a biotechnology company developing treatments for cancer
BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
Wednesday, April 10, 2024BrainStorm Cell Therapeutics Inc a leading developer of adult stem cell therapeutics for neurodegenerative diseases today announced that it received
CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
Tuesday, April 09, 2024CoreRx Inc today announced that it has completed its acquisition of Societal CDMO Inc a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule ther...
Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma
Monday, April 08, 2024Legend Biotech Corporation a global leader in cell therapy announced today the
IMFINZI® (Durvalumab) Significantly Improved Overall Survival and Progression-free Survival for Patients With Limited-stage Small Cell Lung Cancer in ADRIATIC Phase III Trial
Saturday, April 06, 2024Positive highlevel results of the ADRIATIC Phase III trial showed AstraZenecas IMFINZI demonstrated a statistically significant and clinically meaningful
